Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

Article too big to display. Click here to view on the SEC website

Cellectis (NASDAQ:CLLS)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Cellectis Charts.

Cellectis (NASDAQ:CLLS)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Cellectis Charts.

Cellectis SA News

Form EFFECT - Notice of Effectiveness
Friday 24 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 11 December 2024 (2 months ago) • Edgar (US Regulatory)

Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)
Wednesday 11 December 2024 (2 months ago) • GlobeNewswire Inc.

Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting
Wednesday 6 November 2024 (4 months ago) • GlobeNewswire Inc.

Cellectis Provides Business Updates and Financial Results for Third Quarter 2024
Tuesday 5 November 2024 (4 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 31 October 2024 (4 months ago) • Edgar (US Regulatory)

Cellectis to Report Third Quarter 2024 Financial Results on November 4, 2024
Thursday 31 October 2024 (4 months ago) • GlobeNewswire Inc.

Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress
Tuesday 22 October 2024 (4 months ago) • GlobeNewswire Inc.

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
Thursday 12 September 2024 (5 months ago) • Edgar (US Regulatory)

Cellectis Presents Pre-Clinical Evidence of MUC1 CAR T-cells Reducing Triple-Negative Breast Cancer While Preserving Safety
Wednesday 4 September 2024 (6 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 27 August 2024 (6 months ago) • Edgar (US Regulatory)

Cellectis Publishes a Molecular Therapy Article on a SMART DUAL CAR T-cell Approach for Treating Recalcitrant Solid Tumors
Tuesday 27 August 2024 (6 months ago) • GlobeNewswire Inc.

More Cellectis SA News Articles

Societe Generale Effekten

HSBC FTSE EPRA NAR DEV C...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions